NERVES, COUGH, AND IDIOPATHIC PULMONARY FIBROSIS
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It has a poor prognosis with a median survival of approximately 3 years, and whilst new therapies are finally beginning to offer hope of improved survival, most patients will require palliation of sympt...
Main Authors: | Nicholas Kim Harrison, Michael C. Pynn |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2015-05-01
|
Series: | European Medical Journal Respiratory |
Subjects: | |
Online Access: | https://www.emjreviews.com/respiratory/article/nerves-cough-and-idiopathic-pulmonary-fibrosis/ |
Similar Items
-
The Role of Occupational and Environmental Exposures in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Narrative Literature Review
by: Samuel P. Trethewey, et al.
Published: (2018-12-01) -
Idiopathic pulmonary fibrosis: Physicians' perceptions of patient treatment with recently approved drugs
by: Céline Audibert, et al.
Published: (2016-08-01) -
Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
by: Gareth Hughes, et al.
Published: (2016-09-01) -
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
by: Ekaterina Krauss, et al.
Published: (2019-07-01) -
Mucins as a New Frontier in Pulmonary Fibrosis
by: Beatriz Ballester, et al.
Published: (2019-09-01)